I'm watching the Academy Awards. I'm betting on Atonement. You heard it hear first. I also loved Juno. We were going to do a podcast today, but Clink went to the opera. Roy and I and our beloved non-shrink proles went to see Vantage Point. Not shrinky, I leave it to Roy to find a way to blog about it.
You can read about a new Schizophrenia medication in development in the New York Times business section: "Daring to Think Differently About Schizophrenia." LY2140023 works on glutamate receptors, a new approach but the article mentions that preliminary testing shows it to be slightly less effective than Zyprexa.